News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jun 25, 2009

Jun 25, 2009

CDC updates advice on antiviral treatment for flu

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today at the Advisory Committee on Immunization Practices meeting in Atlanta issued updated guidelines for treatment of influenza, including novel H1N1, suggesting basing antiviral selection on laboratory test results when possible.

Jun 26, 2009

Jun 26, 2009

CDC: Flu activity picks up pace, hits summer camps

(CIDRAP News) – An official from the US Centers for Disease Control and Prevention (CDC) said today that the nation just saw its largest weekly increase in cases since the beginning of the novel flu outbreak and that the virus has so far been detected at 34 summer camps in 16 states.

Jul 29, 2009

Jul 29, 2009

Study on pandemic flu risks in pregnancy finds antiviral treatment delays

(CIDRAP News) – Pregnant women who have pandemic H1N1 influenza infection appear to be at greater risk of complications, but some healthcare providers have been hesitant to treat them early with antivirals despite recommendations to do so, researchers from the US Centers for Disease Control and Prevention (CDC) reported today.

Jul 29, 2009

ACIP targets up to 159 million Americans for H1N1 vaccination

(CIDRAP News) – The top US advisory panel on immunizations recommended today that groups totaling up to 159 million people be targeted for vaccination against the pandemic H1N1 influenza virus but that a narrower population of about 41 million have priority if initial supplies are short.

Aug 21, 2009

Aug 21, 2009

First H1N1 vaccine trial data expected in mid-September

(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.

Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.

Oct 22, 2009

Oct 22, 2009

CDC notes change in ethnic pattern of H1N1 impact

(CIDRAP News) – The Centers for Disease Control (CDC) has seen a change in the ethnic distribution of fatal pandemic H1N1 influenza cases, a CDC official reported at a meeting of its vaccine advisory committee today.

Oct 23, 2009

Oct 23, 2009

More clouds in H1N1 vaccine supply picture

(CIDRAP News) – Questions about the tardy US supply of pandemic H1N1 vaccine have increased with the report that most of Novartis's doses may not reach the country until early in 2010 and a European regulatory recommendation that may have implications for the global vaccine supply.

Oct 30, 2009

Oct 30, 2009

WHO experts favor single-dose H1N1 vaccine regimen

(CIDRAP News) – An expert committee that advises the World Health Organization (WHO) today updated its guidance on pandemic H1N1 vaccines, recommending a single dose for most age-groups and advising that any of the forms are safe for pregnant women.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»